Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01651234 · ClinicalTrials.gov registry record · Phase 1

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

A Phase 1 study, sponsored by Green Cross Corporation.

Completed
Registry status
Phase 1
Development phase
48
Enrollment target

NCT01651234: Completed Phase 1 study, sponsored by Green Cross Corporation.

NCT01651234 is a Phase 1 study that has completed, run by Green Cross Corporation. The registered enrollment target is 48 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01651234, a Phase 1 study, has completed, sponsored by Green Cross Corporation.

COMPLETED
Registry status
Phase 1
Development phase
48 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety, tolerability and characterize the PK, PD f\\profile.

Interventions

  • DRUG GCC-4401C
  • DRUG GCC-4401

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2012-03
Est. Completion 2012-08
Phase Phase 1
Green Cross Corporation

4 total trials

What the finished NCT01651234 record still lists

NCT01651234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower).

The record links to 0 conditions, and to 2 interventions - of which GCC-4401C is the first listed.

NCT01651234 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01651234 about?

NCT01651234 is a clinical study titled "A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers". The purpose of this study is to evaluate the safety, tolerability and characterize the PK, PD f\\profile.

What is the current status of trial NCT01651234?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2012-03. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01651234?

The interventions under investigation include: GCC-4401C (DRUG), GCC-4401 (DRUG).

Who is sponsoring clinical trial NCT01651234?

This trial is sponsored by Green Cross Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01651234's enrollment target sits among peer trials

48 1025th of 2000 higher than 948 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01651234, the US trial registry maintained by the National Library of Medicine. NCT01651234 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.